Sign in / Join Now
ETFs & Funds
Human Genome $
Rejects $13/Share Bid from Glaxo $
; Calls It 'Inadequate'
that has been ongoing...it has gotten very ugly
Add a reply...
Latest StockTalks »
people get GSK breaking news and analysis by email alert.
Get email alerts on GSK »
Get latest price
From other sites
Is GlaxoSmithKline (GSK) a Great Stock for Value Investors?
at Zacks.com (Fri, 10:00AM)
GlaxoSmithKline: Robust Pipeline Supports its 5.5% Dividend Yield
at TalkMarkets (Dec 4, 2016)
How to Buy GlaxoSmithKline at a 15% Discount
at TheStreet (Dec 2, 2016)
Glaxo (GSK) Beats Q3 Earnings, Revenues Rise Y/Y
at Zacks.com (Oct 26, 2016)
GlaxoSmithKline Beats Estimates in Strong Third Quarter
at TheStreet (Oct 26, 2016)